Molecular Profiling and Real-world Outcomes of BRAF V600E–Mutated Papillary Thyroid Cancer
Martina Chirra(University of Cincinnati), Trisha M. Wise‐Draper(University of Cincinnati), A Sukari(The Barbara Ann Karmanos Cancer Institute), Jennifer L. Leddon(University of Cincinnati), Farah Abdulla(Caris Life Sciences (United States)), Julie McGrath(Caris Life Sciences (United States)), Jennifer M. Johnson(Thomas Jefferson University), Chukwuemeka Ikpeazu(Sylvester Comprehensive Cancer Center), Dalia El-Gamal(University of Nebraska Medical Center), Hira Shaikh, Andrew Elliott(Caris Life Sciences (United States)), Lova Sun(University of Pennsylvania), Dan P. Zandberg(UPMC Hillman Cancer Center), Anthony N. Karnezis(University of California Davis Medical Center)
Cited by 0
Related Papers
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
|Nature Medicine|2021|521
Mre11 Nuclease Activity Has Essential Roles in DNA Repair and Genomic Stability Distinct from ATM Activation
|Cell|2008|341
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
|Annals of Oncology|2021|328